Potential Novel Pharmacological Therapies for Myocardial Remodeling

Abstract

Left ventricular (LV) remodelling remains an important treatment target in patients after myocardial infarction (MI) and chronic heart failure (CHF). Accumulating evidence has supported the concept that beneficial effects of current pharmacological treatment strategies to improve the prognosis in these patients, such as angiotensin-converting enzyme (ACE… (More)

Topics

  • Presentations referencing similar topics